Skip to content
Menu

JP Morgan Maintains Neutral on Agios Pharmaceuticals, Lowers Price Target to $30

Benzinga Newsdesk 11 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and lowers the price target from $34 to $30.

JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and lowers the price target from $34 to $30.

Read at benzinga.com

← All stock news